Analytical Data
-
Gene name
MPZL2
-
简介
The MPZL2 protein centrally promotes homogeneous cell-to-cell adhesion and mediates important interactions between cells. MPZL2 has the unique ability to promote connections between identical molecules, thus helping to promote cell cohesion and maintain structural integrity. MPZL2 Protein, Human (HEK293, hFc) is the recombinant human-derived MPZL2 protein, expressed by HEK293 , with C-hFc labeled tag.
- Application
-
Alternative Names
Epithelial V-like antigen 1; Mpzl2; EVA-1; EVA1; EVA 1; Eva;
-
Species
Human
-
Source
HEK293
-
Tag
C-hFc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O60487
-
Expression Region
V27-L154
-
Protein Length
Partial
-
Molecular Weight
50-60 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MPZL2 (Myelomonocyte P-Selectin Glycoprotein Ligand 2) is a member of the immunoglobulin superfamily and plays a crucial role in immune cell interactions and adhesion, particularly in the context of inflammation and immune response. Its expression is primarily observed in monocytes, lymphocytes, and certain epithelial cells, where it facilitates cell migration and tissue infiltration during immune responses. Given its significant role in leukocyte trafficking and its potential involvement in various diseases, including autoimmune disorders and cancers, MPZL2 has emerged as a target of interest in biomedical research. The production of recombinant MPZL2 proteins allows scientists to investigate its molecular mechanisms, interactions with other proteins, and expression patterns in different disease states. Studies utilizing recombinant MPZL2 can provide insights into its functional role in cell adhesion processes and help elucidate the pathways that govern immune responses. Furthermore, understanding the structure-function relationship of MPZL2 may pave the way for novel therapeutic strategies aimed at modulating its activity in pathological conditions. The continued exploration of MPZL2, through advanced biotechnological techniques, could yield valuable information contributing to the development of innovative approaches in treating immunological diseases and improving overall immune health.
